BOXL Boxlight Corporation gains 48% May 9, 2018

N/Ahttp://www.priceseries.com/trade/BOXL-Boxlight-Corporation-stock-gains-48-percent-a-Trade-Record-by-priceSeries-2018050120180509.html

AMDA Amedica Corporation gains 15% May 9, 2018

Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and sells a range of medical devices based on its silicon nitride ceramic technology platform in the United States, Europe, and South America. The company offers Valeo silicon nitride spinal fusion devices for use in the cervical and thoracolumbar areas of the spine; and a line of non-silicon nitride spinal surgery products for the treatment of deformity and degenerative spinal procedures. It also develops femoral heads for use in total hip replacements; and femoral condyle components for use in total knee replacements. The company markets and sells its products to surgeons and hospitals directly, as well as through a network of independent sales distributors. Amedica Corporation was founded in 1996 and is headquartered in Salt Lake City, Utah.http://www.priceseries.com/trade/AMDA-Amedica-Corporation-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2018050820180509.html

FI Franks International N.V. gains 16% May 8, 2018

Frank's International N.V. provides various engineered tubular services for the oil and gas exploration and production companies in the United States and internationally. The company operates through four segments: International Services, U.S. Services, Tubular Sales, and Blackhawk. Its tubular services include the handling and installation of multiple joints of pipe to establish a cased wellbore; and the installation of smaller diameter pipe inside a cased wellbore to provide a conduit for produced oil and gas to reach the surface. The company also designs, manufactures, sells, and distributes outside diameter (OD) pipes, connectors, and casing attachments; and provides specialized fabrication and welding services in support of deep water projects, including drilling and production risers, flowlines and pipeline end terminations, and long length tubulars for use as caissons or pilings. In addition, it distributes OD pipes manufactured by third parties; and offers well construction and well intervention rental equipment, services, and products. Frank's International N.V. was founded in 1938 and is headquartered in Amsterdam, the Netherlands.http://www.priceseries.com/trade/FI-Franks-International-NV-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2018041020180508.html

EBIO Eleven Biotherapeutics, Inc. gains 65% May 8, 2018

Eleven Biotherapeutics, Inc., a biologic oncology company, focuses on the design and development of targeted protein therapeutics (TPTs). It develops products based on its proprietary TPT platform and focused on addressing areas of unmet medical needs in cancer. The company's lead product candidates include Vicinium that is in Phase 3 clinical trial in the United States and Canada for the treatment of non-muscle invasive bladder cancer; and Proxinium for use in treating squamous cell carcinoma of the head and neck. It is also developing systemically-administered TPTs, including VB6-845d for the treatment of multiple types of epithelial cell adhesion molecule positive solid tumors. The company was founded in 2008 and is based in Cambridge, Massachusetts.http://www.priceseries.com/trade/EBIO-Eleven-Biotherapeutics-Inc-stock-gains-65-percent-a-Trade-Record-by-priceSeries-2018041920180508.html

ADAP Adaptimmune Therapeutics plc gains 16% May 8, 2018

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on the provision of cancer immunotherapy products based on its proprietary SPEAR T-cell platform. Its platform enables to identify cancer targets; find and genetically engineer T-cell receptors (TCR); and produce TCR therapeutic candidates for administration to patients. The company's lead program includes NY-ESO-1 and LAGE-1a cancer antigens, which are in Phase I/II clinical trials for patients with solid tumors, as well as hematological cancer types, including synovial sarcoma, multiple myeloma, non-small cell lung cancer (NSCLC), and ovarian cancer; and pilot trial for myxoid round cell liposarcoma. It is also developing MAGE A-10 peptide that is in Phase I/II clinical trials to treat urothelial (bladder), melanoma, and head and neck cancers, as well as NSCLC; AFP SPEAR T-cell therapeutic candidate that has completed preclinical testing for targeting a peptide associated with hepatocellular carcinoma; and MAGE-A4 to treat urothelial (bladder), melanoma, head and neck, esophageal and gastric, and ovarian cancer, as well as NSCLC. It has a strategic collaboration and licensing agreement with GlaxoSmithKline for the development and commercialization of the NY-ESO SPEAR T-cell program; and strategic alliance with MD Anderson Cancer Center for the development of T-cell therapies for various cancers. The company also has a clinical trial collaboration agreement with Merck & Co., Inc. for the assessment of NY-ESO SPEAR T-cell in combination with anti-programmed death-1 inhibitor in patients with multiple myeloma; and a research, collaboration, and license agreement with Universal Cells, Inc. to gene editing and HLA-engineering technology, as well as a collaboration agreement with Bellicum Pharmaceutical Inc. to evaluate, develop, and commercialize next generation T-cell therapies. Adaptimmune Therapeutics plc was founded in 2014 and is headquartered in Abingdon, the United Kingdom.http://www.priceseries.com/trade/ADAP-Adaptimmune-Therapeutics-plc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2018041020180508.html

TLRD Tailored Brands, Inc. gains 22% May 7, 2018

The Men's Wearhouse, Inc. operates as a specialty apparel retailer in the United States, Puerto Rico, and Canada. The company operates in two segments, Retail and Corporate Apparel.http://www.priceseries.com/trade/TLRD-Tailored-Brands-Inc-stock-gains-22-percent-a-Trade-Record-by-priceSeries-2018032620180507.html

IMMY Imprimis Pharmaceuticals, Inc. gains 19% May 7, 2018

Imprimis Pharmaceuticals, Inc. engages in the development, production, and sale of medications to physicians and patients in the United States. Its ophthalmology program consists of Dropless Therapy injectable and LessDrops topical formulations. The company also offers a conscious sedation medication, the IV Free MKO Melt, an alternative to intravenous sedation. It focuses on providing ophthalmology programs and medications for glaucoma, wet age-related macular degeneration, diabetic macular edema, and chronic dry eye disease. The company's medicine business includes medications used in several therapeutic areas, including oncology, autoimmunity, chronic infectious diseases, and endocrine and metabolic diseases; and urology business comprises a series of injectable erectile dysfunction formulations for patients that are refractory to or are otherwise unable to take phosphodiesterase type 5 inhibitors, such as sildenafil, tadalafil, and vardenafil. In addition, it develops PPS-DR (pentosan polysulfate sodium delayed-release) formulations as alternatives to Elmiron for patients diagnosed with interstitial cystitis; and develops and sells therapeutic alternatives to Daraprim, Thiola, and Calcium Disodium Versenate. The company was formerly known as Transdel Pharmaceuticals, Inc. and changed its name to Imprimis Pharmaceuticals, Inc. in February 2012. Imprimis Pharmaceuticals, Inc. was founded in 1998 and is headquartered in San Diego, California.http://www.priceseries.com/trade/IMMY-Imprimis-Pharmaceuticals-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2018040420180507.html

LENS Presbia PLC gains 30% May 4, 2018

Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. It operates primarily in the United States, Australia, Canada, Ireland, South Korea, the Netherlands, and the United Kingdom. The company was founded in 2014 and is headquartered in Dublin, Ireland.http://www.priceseries.com/trade/LENS-Presbia-PLC-stock-gains-30-percent-a-Trade-Record-by-priceSeries-2018050320180504.html

BTE Baytex Energy Corp gains 49% May 4, 2018

Baytex Energy Corp., an oil and gas company, engages in the acquisition, development, and production of crude oil and natural gas in the Western Canadian Sedimentary Basin and Eagle Ford in the United States. The company offers heavy oil, light oil, condensate, and natural gas liquids. As of March 7, 2017, it had proved plus probable reserve of 406 million barrels of oil equivalent; and proved reserves of 253 million barrels of oil equivalent. The company was founded in 1993 and is headquartered in Calgary, Canada.http://www.priceseries.com/trade/BTE-Baytex-Energy-Corp-stock-gains-49-percent-a-Trade-Record-by-priceSeries-2018040420180504.html

BLIN Bridgeline Digital Inc gains 43% May 4, 2018

Bridgeline Digital, Inc. operates as a digital engagement company in the United States. The company's iAPPS platform enables companies and developers to create Websites, Web applications, and online stores. It offers iAPPS Experience Manager, a marketing automation engine and content management system; iAPPS Content Manager that enables non-technical users to create, edit, and publish content via a browser-based interface; and iAPPS Commerce, an online B2B and B2C e-commerce solution, which allows users to manage domestic and international commerce initiatives. The company also provides iAPPS Marketier, an online marketing management solution that helps marketers drive to their sites through personalized and targeted marketing automation flows; and iAPPS Analyzer to manage, measure, and optimize Web properties by recording detailed events and mining data for statistical analysis. In addition, it offers iAPPS Social, a social media management solution that empowers customers to set up customized watch lists; and iAPPSds, a Web content management and e-commerce platform to multi-unit organizations and franchises. Further, the company provides digital strategy, Web design and development, usability engineering, information architecture, and search engine optimization services; co-location, application monitoring, emergency response, version control, load balancing, managed firewall security, and virus protection services; and shared, dedicated, and Software as a Service hosting services. It serves vertical markets, such as financial services, franchises/multi-unit organizations, retail brand names, health services and life sciences, technology, credit unions and regional banks, and associations and foundations through its direct sales force. The company was formerly known as Bridgeline Software, Inc. and changed its name to Bridgeline Digital, Inc. in March 2010. Bridgeline Digital, Inc. was founded in 2000 and is headquartered in Burlington, Massachusetts.http://www.priceseries.com/trade/BLIN-Bridgeline-Digital-Inc-stock-gains-43-percent-a-Trade-Record-by-priceSeries-2018050320180504.html